Pfizer shows profit growth from cost cuts and steadier COVID sales

Share it

“Our revenue volatility is largely in the past as COVID-related uncertainties have diminished,” Pfizer’s finance chief David Denton said.

Leave a Comment

Your email address will not be published. Required fields are marked *